Zainab M. Elsayed

891 citations
38 papers · 713 · h-index 16

Impact in

  • Organic Chemistry top 5%
    • Synthesis and biological activity
    • Synthesis and Catalytic Reactions
    • Click Chemistry and Applications
    • Synthesis and Biological Evaluation
  • Toxicology top 5%

Papers in

  • Organic Chemistry 24
    • Synthesis and biological activity 15
    • Synthesis and Catalytic Reactions 8
    • Click Chemistry and Applications 3
    • Quinazolinone synthesis and applications 3
  • Molecular Biology 23
    • Enzyme function and inhibition 11
    • Cancer therapeutics and mechanisms 8
Co-authors
Wagdy M. Eldehna (37 shared papers)Hatem A. Abdel‐Aziz (17 shared papers)Tarfah Al‐Warhi (9 shared papers)Claudiu T. Supuran (11 shared papers)Alessio Nocentini (9 shared papers)Mahmoud A. El Hassab (12 shared papers)Mohammad M. Al‐Sanea (7 shared papers)Eslam B. Elkaeed (8 shared papers)
Journals
Bioorganic Chemistry (8 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (6 papers)International Journal of Pharmaceutics (3 papers)European Journal of Medicinal Chemistry (3 papers)Drug Design Development and Therapy (2 papers)
Partner nations
EgyptSaudi ArabiaItaly

In The Last Decade

Zainab M. Elsayed

34 papers receiving 709 citations

Peers

Zainab M. Elsayed
Comparison fields: 5 of 59
  • Organic Chemistry 494
  • Toxicology 39
  • Molecular Biology 398
  • Pharmacology 84
  • Computational Theory and Mathematics 59
Replace Radwan El‐Haggar with:
Radwan El‐Haggar Egypt
Haytham O. Tawfik Egypt
Mai E. Shoman Egypt
Chandrakant Bagul India
Marwa G. El‐Gazzar Egypt
Ghada H. Al-Ansary Egypt
Yassin M. Nissan Egypt
Mohammed T. El‐Saadi Egypt
Ahmed T. A. Boraei Egypt
Hanumappa Ananda India
Zainab M. Elsayed relative to Radwan El‐Haggar Egypt Radwan El‐Haggar's profile →
Citations per field
00.5×1.5×
Radwan El‐Haggar · 1×
Citations per year

Countries citing papers authored by Zainab M. Elsayed

Since Specialization
Citations

This map shows the geographic impact of Zainab M. Elsayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zainab M. Elsayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zainab M. Elsayed more than expected).

Fields of papers citing papers by Zainab M. Elsayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zainab M. Elsayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zainab M. Elsayed. The network helps show where Zainab M. Elsayed may publish in the future.

Co-authors

The 25 scholars most cited alongside Zainab M. Elsayed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zainab M. Elsayed Line = papers co-authored together Zainab M. Elsayed links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#Work
1
3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies
European Journal of Medicinal Chemistry ·Abdulsalam A. M. Alkhaldi, Mohammad M. Al‐Sanea, Alessio Nocentini, Wagdy M. Eldehna, Zainab M. Elsayed, Alessandro Bonardi, Mahmoud F. Abo-Ashour, Ashraf K. El‐Damasy, Mohammed S. Abdel‐Maksoud, Tarfah Al‐Warhi, Paola Gratteri, Hatem A. Abdel‐Aziz, Claudiu T. Supuran, Radwan El‐Haggar
202064
2
Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4,5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activity
Scientific Reports ·Wagdy M. Eldehna, Mahmoud A. El Hassab, Zainab M. Elsayed, Tarfah Al‐Warhi, Hazem Elkady, Mahmoud F. Abo-Ashour, Mohammed A. S. Abourehab, Ibrahim H. Eissa, Hatem A. Abdel‐Aziz
202262
3
Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors
European Journal of Medicinal Chemistry ·Moataz A. Shaldam, Wagdy M. Eldehna, Alessio Nocentini, Zainab M. Elsayed, Tamer M. Ibrahim, Rofaida Salem, Ramadan A. El-Domany, Clemente Capasso, Hatem A. Abdel‐Aziz, Claudiu T. Supuran
202159
4
Benzofuran-Based Carboxylic Acids as Carbonic Anhydrase Inhibitors and Antiproliferative Agents against Breast Cancer
ACS Medicinal Chemistry Letters ·Wagdy M. Eldehna, Alessio Nocentini, Zainab M. Elsayed, Tarfah Al‐Warhi, Nada Aljaeed, Ohoud J. Alotaibi, Mohammad M. Al‐Sanea, Hatem A. Abdel‐Aziz, Claudiu T. Supuran
202058
5
Development of novel isatin–nicotinohydrazide hybrids with potent activity against susceptible/resistantMycobacterium tuberculosisand bronchitis causing–bacteria
Journal of Enzyme Inhibition and Medicinal Chemistry ·Zainab M. Elsayed, Wagdy M. Eldehna, Marwa M. Abdel‐Aziz, Mahmoud A. El Hassab, Eslam B. Elkaeed, Tarfah Al‐Warhi, Hatem A. Abdel‐Aziz, Sahar M. Abou‐Seri, Eman R. Mohammed
202148
6
<p>Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety</p>
Drug Design Development and Therapy ·Mohammad M. Al‐Sanea, Lizaveta Gotina, Mamdouh F. A. Mohamed, Della Grace Thomas Parambi, Hesham Anwar, Bijo Mathew, Bahaa G. M. Youssif, Khalid Saad Alharbi, Zainab M. Elsayed, Mohamed A. Abdelgawad, Wagdy M. Eldehna
202042
7
Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors
Journal of Enzyme Inhibition and Medicinal Chemistry ·Moataz A. Shaldam, Hadia Almahli, Andrea Angeli, Rehab Mustafa Badi, Eman F. Khaleel, Abdelrahman I. Zain-Alabdeen, Zainab M. Elsayed, Eslam B. Elkaeed, Rofaida Salem, Claudiu T. Supuran, Wagdy M. Eldehna, Haytham O. Tawfik
202337
8
Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancer
Journal of Enzyme Inhibition and Medicinal Chemistry ·Wagdy M. Eldehna, Rofaida Salem, Zainab M. Elsayed, Tarfah Al‐Warhi, Hamada R. Knany, Rezk R. Ayyad, Thamer Bin Traiki, Maha‐Hamadien Abdulla, Rehan Ahmad, Hatem A. Abdel‐Aziz, Radwan El‐Haggar
202136
9
Development of 3-methyl/3-(morpholinomethyl)benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cells
Journal of Enzyme Inhibition and Medicinal Chemistry ·Mohammad M. Al‐Sanea, Ghada H. Al-Ansary, Zainab M. Elsayed, Raed M. Maklad, Eslam B. Elkaeed, Mohamed A. Abdelgawad, Syed Nasir Abbas Bukhari, Marwa M. Abdel‐Aziz, Howayda Suliman, Wagdy M. Eldehna
202130
10
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights
Drug Design Development and Therapy ·Tarfah Al‐Warhi, Ahmed M. El Kerdawy, Mohamed A. Said, Amgad Albohy, Zainab M. Elsayed, Nada Aljaeed, Eslam B. Elkaeed, Wagdy M. Eldehna, Hatem A. Abdel‐Aziz, Miral A. Abdelmoaz
202229
11
Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors
International Journal of Molecular Sciences ·Moataz A. Shaldam, Alessio Nocentini, Zainab M. Elsayed, Tamer M. Ibrahim, Rofaida Salem, Ramadan A. El-Domany, Clemente Capasso, Claudiu T. Supuran, Wagdy M. Eldehna
202128
12
Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens
RSC Advances ·Tarfah Al‐Warhi, Diaaeldin M. Elimam, Zainab M. Elsayed, Marwa M. Abdel‐Aziz, Raed M. Maklad, Ahmed A. Al‐Karmalawy, Kamyar Afarinkia, Mohammed A. S. Abourehab, Hatem A. Abdel‐Aziz, Wagdy M. Eldehna
202227
13
Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2/STAT-3 inhibitors: Design, synthesis and biological assessments
Bioorganic Chemistry ·Heba A. Elsebaie, Maha‐Hamadien Abdulla, Zainab M. Elsayed, Moataz A. Shaldam, Haytham O. Tawfik, Samar N Morsy, Mansoor-Ali Vaali Mohammed, Thamer Bin Traiki, Eslam B. Elkaeed, Hatem A. Abdel‐Aziz, Wagdy M. Eldehna
202422
14
Identification of sulphonamide-tethered N -((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease
Journal of Enzyme Inhibition and Medicinal Chemistry ·Mai H. ElNaggar, Abdullah A. Elgazar, Ghada Gamal, Shimaa M. Hamed, Zainab M. Elsayed, Mohamed K. El‐Ashrey, Amira Abood, Mahmoud A. El Hassab, Ahmed M. Soliman, Ramadan A. El-Domany, Farid A. Badria, Claudiu T. Supuran, Wagdy M. Eldehna
202319
15
1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights
Molecules ·Tarfah Al‐Warhi, Hadia Almahli, Raed M. Maklad, Zainab M. Elsayed, Mahmoud A. El Hassab, Ohoud J. Alotaibi, Nada Aljaeed, Rezk R. Ayyad, Hazem A. Ghabour, Wagdy M. Eldehna, Mohamed K. El‐Ashrey
202317
16
Development of potent nanosized isatin-isonicotinohydrazide hybrid for management of Mycobacterium tuberculosis
International Journal of Pharmaceutics ·Wagdy M. Eldehna, Mahmoud A. El Hassab, Nahla A. Abdelshafi, Fatma Al-Zahraa Sayed, Mohamed Farès, Sara T. Al‐Rashood, Zainab M. Elsayed, Marwa M. Abdel‐Aziz, Eslam B. Elkaeed, Mahmoud Elsabahy, Noura G. Eissa
202117
17
Development of potent nanosized carbonic anhydrase inhibitor for targeted therapy of hypoxic solid tumors
International Journal of Pharmaceutics ·Wagdy M. Eldehna, Mahmoud A. El Hassab, Nahla A. Abdelshafi, Rana A. Eissa, Nadeen H. Diab, Ekram H. Mohamed, Mamdouh A. Oraby, Sara T. Al‐Rashood, Rana G. Eissa, Zainab M. Elsayed, Alessio Nocentini, Claudiu T. Supuran, Mahmoud Elsabahy, Noura G. Eissa
202214
18
Discovery of new sulfonamide-tethered 2-aryl-4-anilinoquinazolines as the first-in-class dual carbonic anhydrase and EGFR inhibitors
International Journal of Biological Macromolecules ·Wagdy M. Eldehna, Zainab M. Elsayed, Andrea Ammara, Mahmoud A. El Hassab, Hadia Almahli, Mohamed Farès, Alessio Nocentini, Claudiu T. Supuran, Sahar M. Abou‐Seri
202413
19
Design, synthesis, and in silico insights of novel N’-(2-oxoindolin-3-ylidene)piperidine-4-carbohydrazide derivatives as VEGFR-2 inhibitors
Bioorganic Chemistry ·Wagdy M. Eldehna, Youmna A Habib, Abeer E. Mahmoud, Mohamed F. Barghash, Zainab M. Elsayed, Ahmed E. Elsawi, Raed M. Maklad, Mahmoud Rashed, Amira Khalil, Sherif Hammad, Mamdouh M. Ali, Ahmed M. El Kerdawy
202411
20
Identification of indole-grafted pyrazolopyrimidine and pyrazolopyridine derivatives as new anti-cancer agents: Synthesis, biological assessments, and molecular modeling insights
Bioorganic Chemistry ·Wagdy M. Eldehna, Haytham O. Tawfik, Maha‐Hamadien Abdulla, Mohamed S. Nafie, ‪Heba Aref‬‏, Moataz A. Shaldam, Noura Alhassan, Omar Al Obeed, Zainab M. Elsayed, Hatem A. Abdel‐Aziz
202410

About Zainab M. Elsayed

Zainab M. Elsayed is a scholar working on Organic Chemistry, Molecular Biology, Toxicology, Infectious Diseases and Pharmacology, having authored 38 papers that have together received 713 indexed citations. Recurring topics across this work include Synthesis and biological activity (15 papers), Enzyme function and inhibition (11 papers), Synthesis and Catalytic Reactions (8 papers), Cancer therapeutics and mechanisms (8 papers), Bioactive Compounds and Antitumor Agents (4 papers), Click Chemistry and Applications (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Quinazolinone synthesis and applications (3 papers). The work is most often cited by research in Organic Chemistry (494 citations), Toxicology (39 citations), Molecular Biology (398 citations), Pharmacology (84 citations) and Computational Theory and Mathematics (59 citations). Zainab M. Elsayed has collaborated with scholars based in Egypt, Saudi Arabia and Italy. Frequent co-authors include Wagdy M. Eldehna, Hatem A. Abdel‐Aziz, Tarfah Al‐Warhi, Claudiu T. Supuran, Alessio Nocentini, Mahmoud A. El Hassab, Mohammad M. Al‐Sanea, Eslam B. Elkaeed, Rofaida Salem and Moataz A. Shaldam. Their work appears in journals such as Bioorganic Chemistry, Journal of Enzyme Inhibition and Medicinal Chemistry, International Journal of Pharmaceutics, European Journal of Medicinal Chemistry and Drug Design Development and Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Radwan El‐HaggarBreakdown of academic impact, for papers by Haytham O. TawfikBreakdown of academic impact, for papers by Mai E. ShomanBreakdown of academic impact, for papers by Chandrakant BagulBreakdown of academic impact, for papers by Marwa G. El‐GazzarBreakdown of academic impact, for papers by Ghada H. Al-AnsaryBreakdown of academic impact, for papers by Yassin M. NissanBreakdown of academic impact, for papers by Mohammed T. El‐SaadiBreakdown of academic impact, for papers by Ahmed T. A. BoraeiBreakdown of academic impact, for papers by Hanumappa Ananda